Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Debt Ratio (2018 - 2026)

Mesoblast's (MEOBF) quarterly Debt Ratio came in at 0.01 in Q2 2026, down 80.14% year-over-year from 0.07 in Q2 2025, and down 83.93% quarter-over-quarter from 0.09 in Q4 2025.

Analysis

Mesoblast (MEOBF) Debt Ratio (2018 - 2026) Analysis & Trends

Mesoblast has disclosed Debt Ratio across 9 years of filings, most recently posting 0.01 for Q2 2026.

  • In Q2 2026, Debt Ratio fell 80.14% year-over-year to 0.01; the TTM figure through Jun 2026 stood at 0.01 (down 80.14% YoY), while the FY2026 annual figure was 0.01, down 80.14% from the prior year.
  • Debt Ratio came in at 0.01 for Q2 2026 at Mesoblast, down from 0.09 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.09 in Q4 2025 to a low of 0.01 in Q2 2022.
  • Average Debt Ratio over 5 years is 0.02, with a median of 0.01 recorded in 2023.
  • Year-over-year, Debt Ratio sank 89.39% in 2022 and jumped 233.15% in 2025.
  • Over 5 years, Debt Ratio stood at 0.01 in 2022, then soared by 43.24% to 0.01 in 2023, then soared by 110.45% to 0.03 in 2024, then soared by 218.39% to 0.09 in 2025, then slumped by 83.93% to 0.01 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.01 in Q2 2026, 0.09 in Q4 2025, and 0.07 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Krystal Biotech 10.27 Bn 9.42 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.20 Bn 5.20 Bn - 0.22
3 Iovance Biotherapeutics 3.78 Bn 3.49 Bn 55.72 Mn -
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 0.09
5 uniQure 3.06 Bn 3.06 Bn 5.49 Mn 0.05
6 Beam Therapeutics 2.68 Bn 2.68 Bn - 0.08
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 0.55
8 Sarepta Therapeutics 2.35 Bn 1.55 Bn 251.87 Mn 0.27
9 Vericel 2.00 Bn 1.83 Bn 56.40 Mn -
10 Mesoblast 246.02 Mn 143.11 Mn - 0.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.01
Dec 31, 2025 0.09
Jun 30, 2025 0.07
Dec 31, 2024 0.03
Jun 30, 2024 0.02
Dec 31, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.07
Jun 30, 2021 0.07
Mar 31, 2021 0.07
Dec 31, 2020 0.06
Sep 30, 2020 0.05
Jun 30, 2020 0.04
Mar 31, 2020 0.04